| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.22 | 6e-08 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-06 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-05 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-05 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |